Drug Index

Lomustine

 
print

Mechanism :

Lomustine alkylates DNA and RNA, it is not cross resistant with other alkylators. As with other nitrosoureas, it may also inhibit several key enzymatic processes by carbamoylation of amino acids in proteins.


Indication :

• Brain tumors

• Hodgkin’s Lymphoma


Contraindications :

Should not be given to individuals who have demonstrated a previous hypersensitivity to it.


Dosing :

130 mg/sqm as a single oral dose once every 6 weeks. Round off the dose to nearest 5 mg.

Compromised bone marrow: 100 mg/m² orally once every 6 weeks.


Adverse Effect :

Delayed myelosuppression, anemia, thrombocytopenia, leukopenia, acute leukemia, bone marrow dysplasia, nausea and vomiting, progressive azotemia, decrease in kidney size and renal failure have been reported in patients who received large cumulative doses after prolonged therapy, disorientation, lethargy, ataxia, and dysarthria.


Interaction :

Contraindicated:
Adenovirus vaccine, live, BCG live intravesical, Influenza nasal vaccine live, Measles/mumps/rubella vaccine live, Rotavirus vaccine live, Smallpox vaccine (live vaccinia virus), Typhoid vaccine live, Varicella vaccine live, Yellow fever vaccine live, Zoster vaccine live.
Avoid/Use Alternative:
Alefacept, Deferiprone, Natalizumab, Palifermin, Radium Ra 223 dichloride, Sipuleucel-T, Thiotepa.


07/21/2019 21:52:32 Lomustine
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0